Pasar al contenido principal

Targeting and Tinkering with Interaction Networks

14 Abr 08

BARCELONA, Spain. 14 - 16 APRIL, 2008 An IRB Barcelona and BBVA Foundation conference that will provide an interdisciplinary forum for researchers interested in interactions, pathways, networks and drug design to meet and discuss the latest advances in this field.



Complex systems are often networked, and biology is no exception. The follow-up experiments to the genome sequencing projects are showing that molecules in living things are also highly connected, which helps to explain how such great complexity can be achieved by a comparatively small set of molecules. Thus, the many thousands of biomolecular interactions that are now known represent a powerful dataset for interrogating all aspects of biology. Although there has traditionally been cynicism about the possibility of re-designing systems behaviour by tinkering with pathways and targeting interactions with small-molecules, much exciting recent research suggests that this is now possible.

This conference gathers together many of the leading minds in the world of interactions, pathways, networks and drug design with the aim to summarise these findings and suggest how future developments will unfold.

Organised by IRB Barcelona with the collaboration of the Banco Bilbao Vizcaya Argentaria Foundation (fBBVA).

Hosted by the Institut d'Estudis Catalans (IEC).

Download the Conference Programme (PDF)

Download the Conference Poster (PDF)

fbbva iec

For more information, please contact the Barcelona BioMed Conference Secretariat at

Registration deadline: February 29, 2008

There is no registration fee for this conference, but the number of participants is limited.

Participants are invited to submit abstracts, a number of which will be selected for short talk presentations. Abstracts should include a title, authors, affiliations, summary (max 250 words) and references.


The BARCELONA BIOMED CONFERENCE on TARGETING AND TINKERING WITH INTERACTION NETWORKS will be hosted by the Institut d'Estudis Catalans (IEC) in the heart of downtown Barcelona. Talks will take place in the Sala Prat de Riba.

Institut d'Estudis Catalans
C. del Carme, 47
08001 Barcelona

Tel +34 932 701 620
Fax +34 932 701 180


How to reach the IEC by public transport:

  • metro Metro
    Plaça Catalunya (lines 1 and 3)
    Liceu (line 3)
  • ffcc FGC
    Plaça Catalunya (train from Sarrià)
  • renfe Renfe
    Plaça Catalunya
  • bus Buses
    41, 55, 141 (Plaça Catalunya stop)
    14, 18, 59, 91 (Rambla stop)

Speakers will be lodged at the Hotel Catalonia Ramblas
c/ Pelayo, 28
08001 Barcelona
Tel. +34 93.316.84.00
Fax. +34 93.316.84.01

Help in finding accommodation in Barcelona can be obtained through the following websites:

For more information about Barcelona, you can also consult the IRB Barcelona web section "Living in Barcelona".

fbbva iec



  • Patrick Aloy (Institute for Research in Biomedicine, Barcelona, ES)
  • Rob Russell (European Molecular Biology Laboratory, Heidelberg, DE)

Confirmed speakers:

  • Ewan Birney (European Bioinformatics Institute-EMBL, Hinxton, UK)
  • Peer Bork (European Molecular Biology Laboratory, Heidelberg, DE)
  • David De Graaf (Pfizer, Cambridge, USA)
  • Victor de Lorenzo (Centro Nacional de Biotecnologia, Madrid, ES)
  • Anne-Claude Gavin (European Molecular Biology Laboratory, Heidelberg, DE)
  • Frank Holstege (Universitair Medisch Centrum, Utrecht, NL)
  • Trey Ideker (University of California at San Diego, USA)
  • Glyn Williams (Astex therapeutics Ltd, Cambridge, UK)
  • Jay Keasling (University of California at Berkeley, USA)
  • Joseph Lehar (CombinatoRx Inc, Cambridge, USA)
  • Wendell Lim (University of California at San Francisco, USA)
  • Tony Pawson (Samuel Lunenfeld Research Institute, Toronto, CA)
  • Luis Serrano (Center for Genomic Regulation, Barcelona, ES)
  • Kristina Schmidt (Graffinity Pharmaceuticals GmbH, Heidelberg, DE)
  • Mike Snyder (Yale University, New Haven, USA)
  • Giulio Superti-Furga (Research Center for Molecular Medicine, Vienna, AT)
  • Alfonso Valencia (Centro Nacional de Investigaciones Oncológicas, Madrid, ES)
  • Marc Vidal (Center for Cancer Systems Biology and Dana Farber Cancer Institute, Boston, USA)
  • Gerhard Wagner (Harvard Medical School, Boston, USA)
  • Ron Weiss (Princeton University, New Jersey, USA)
  • Jim Wells (University of California at San Francisco, USA)

For more information, please contact the Barcelona BioMed Conference Secretariat at